MedPath
HSA Approval

VOTAZINE TABLET 25 mg

SIN03899P

VOTAZINE TABLET 25 mg

VOTAZINE TABLET 25 mg

February 22, 1990

DUOPHARMA (SINGAPORE) PTE LTD

DUOPHARMA (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDUOPHARMA (SINGAPORE) PTE LTD
Licence HolderDUOPHARMA (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R06AD02

promethazine

Manufacturer Information

DUOPHARMA (SINGAPORE) PTE. LTD.

DUOPHARMA (M) SDN BHD

Active Ingredients

PROMETHAZINE THEOCLATE

25 mg

Promethazine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VOTAZINE TABLET 25 mg - HSA Approval | MedPath